Last month, China released its 14th Five-Year Plan (2021-2025) for the energy sector. While clean and low-carbon may be the keywords on paper, in reality, Beijing will continue rely on coal to power its economy and energy transitions, writes the author. Read the post on the Baker Institute Blog.
Once the Covid-19 pandemic has subsided, the new Israeli government will face serious flaws in, among other things, the territorial dimensions of President Trump's “Deal of the Century,” writes Middle East fellow Gilead Sher for the Baker Institute blog: https://bit.ly/2VvkBPw
Baker Institute director Edward P. Djerejian, former ambassador to Israel and to Syria, appeared on Al-Jazeera's "From Washington"
program to discuss the possible consequences of Jamal Khashoggi's disappearance (Arabic): https://youtu.be/J7-xALrG_3s.
Days after the attacks on the World Trade Center, William Martin, the Harry and Hazel Chavanne Senior Fellow in Religion and Public Policy and Chavanne Emeritus Professor in Rice’s Department of Sociology, spoke to a gathering of Rice University students, faculty and staff. These are his remarks.
Baker Institute director Edward P. Djerejian comments on a welcome moment of nonpartisanship after the April 21, 2018, funeral for former first lady Barbara Bush.
The Texas House of Representatives is considering House Bill 3256, which would legalize syringe exchange programs (SEPs) as a means of reducing the transmission of infectious and communicable diseases among people who inject drugs. On April 25, William Martin, director of the Drug Policy Program, appeared before the Texas House Committee on Public Health to testify in support of HB 3256. Martin also authored an op-ed in TribTalk supporting the establishment of SEPs.
Drug policy has experienced an interesting shift recently. Along with legalization of medical and recreational marijuana, many states are also reducing penalties for nonviolent drug offenses and placing greater focus on treatment for drug users. The emphasis on treatment and rehabilitation for drug users is the result of many factors, including recognition that the drug war has not reduced drug use, a desire to reduce the prison population and save money, and a surge in the rate of overdoses from opioid and heroin use. What remains to be seen is whether the current popularity of drug treatment will become a more permanent feature of drug policy. In this Baker Institute Viewpoints series, five experts on drug policy examine the question, “Is the current emphasis on treatment in drug policy a short-term trend or is it here to stay?”
Katharine Neill Harris, William MartinDecember 19, 2014